Search results
22 maj 2023 · Bullous systemic lupus erythematosus (BSLE) is a rare manifestation of systemic lupus erythematosus. It has clinical and histological features that may lead to misdiagnosis and delayed treatment of this easily treatable condition.
6 paź 2017 · The aim of this guideline was to produce recommendations for the management of adult lupus patients in the UK that cover the diagnosis, assessment and monitoring of lupus and the treatment of mild, moderate and severe active lupus disease, but which do not imply a legal obligation.
Oral dapsone is sometimes used for rheumatologic skin diseases. It is most commonly used to treat some forms of cutaneous lupus erythematosus (including bullous lupus), vasculitis, and conditions due to increased neutrophils (neutrophilic dermatoses).
Bullous lupus erythematosus is a subtype of acute cutaneous lupus erythematosus (ACLE) characterized by subepidermal vesiculobullous skin lesions. Dapsone is occasionally used as an adjunctive treatment for CLE, and is thought to be particularly useful in patients with bullous disease. 11 However, there is a dearth of studies in the literature ...
7 paź 2021 · Dapsone is the initial treatment of choice for bullous systemic lupus erythematosus. [2, 34] The response is usually dramatic, with cessation of new blister formation within 1-2 days and...
16 cze 2023 · The diagnosis of systemic lupus erythematosus (SLE) is based upon the judgment of an experienced clinician who recognizes characteristic constellations of symptoms and signs in the setting of supportive serologic studies after excluding alternative diagnoses.
4 sie 2011 · Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6 and type VII collagen.
